Suchergebnisse - "Nguyen, Tamia"

PubPharm (14)

1

Immunophenotypic characterisation of acute myeloid leukaemia with UBTF tandem duplications

enthalten in: British journal of haematology | 2024

von Harrop, S. | Nguyen, P. | Robinson, S. | +8

2

Evaluation of T-cell clonality by anti-TRBC1 antibody-based flow cytometry and correlation with T-cell receptor sequencing

enthalten in: British journal of haematology | 2024

von Nguyen, P. | Nguyen, T. | Wilson, C. | +6

3

Targeting Molecular Measurable Residual Disease and Low-Blast Relapse in AML With Venetoclax and Low-Dose Cytarabine : A Prospective Phase II Study (VALDAC)

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Tiong, I. | Hiwase, D. | Abro, E. | +17

4

Evaluation of T‐cell clonality by anti‐TRBC1 antibody‐based flow cytometry and correlation with T‐cell receptor sequencing

enthalten in: British Journal of Haematology | 2024

von Nguyen, P. | Nguyen, T. | Wilson, C. | +6

5

Persistence of UBTF tandem duplications in remission in acute myeloid leukaemia

enthalten in: EJHaem | 2023

von Harrop, S. | Nguyen, P. | Byrne, D. | +9

6

Variant acute promyelocytic leukaemia with novel NAB2::RARA fusion shows clinical all-trans retinoic acid and arsenic trioxide sensitivity

enthalten in: British journal of haematology | 2023

von Ng Liet Hing, M. | Ryland, G. | Nguyen, T. | +8

7

Clonal hematopoiesis, myeloid disorders and BAX-mutated myelopoiesis in patients receiving venetoclax for CLL

enthalten in: Blood | 2022

von Blombery, P. | Lew, T. | Dengler, M. | +15

CommentIn: Blood. 2022 Feb 24;139(8):1124-1126. - PMID 35201333

8

Single-cell sequencing demonstrates complex resistance landscape in CLL and MCL treated with BTK and BCL2 inhibitors

enthalten in: Blood advances | 2022

von Thompson, E. | Nguyen, T. | Kankanige, Y. | +10

9

Clonal independence of JAK2 and CALR or MPL mutations in comutated myeloproliferative neoplasms demonstrated by single cell DNA sequencing

enthalten in: Haematologica | 2021

von Thompson, E. | Nguyen, T. | Kankanige, Y. | +10

10

BTK inhibitor therapy is effective in patients with CLL resistant to venetoclax

enthalten in: Blood | 2020

von Lin, V. | Lew, T. | Handunnetti, S. | +8

CommentIn: Blood. 2020 Jun 18;135(25):2205-2207. - PMID 32556131